Allen Institute launches $400M Brain Health Accelerator to develop gene therapies for brain diseases
The Allen Institute is shifting from mapping the brain to treating brain disease with a $400 million initiative targeting Alzheimer's, Parkinson's, ALS, and Huntington's. The Brain Health Accelerator aims to develop gene therapies that target specific cells and circuits affected by disease, with clinical trials expected within five years.